Cargando…

Impact of the Gestational Diabetes Diagnostic Criteria during the Pandemic: An Observational Study

Objective: To analyze the effect of applying alternative diagnostic criteria for gestational diabetes mellitus (GDM) during the COVID-19 pandemic on GDM prevalence and obstetrical and perinatal outcomes, in comparison to usual diagnostic approaches. Methods: Data from women referred to GDM diagnosis...

Descripción completa

Detalles Bibliográficos
Autores principales: Molina-Vega, María, Gutiérrez-Repiso, Carolina, Lima-Rubio, Fuensanta, Suárez-Arana, María, Linares-Pineda, Teresa María, Cobos Díaz, Andrés, Tinahones, Francisco J., Morcillo, Sonsoles, Picón-César, María J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8585066/
https://www.ncbi.nlm.nih.gov/pubmed/34768425
http://dx.doi.org/10.3390/jcm10214904
_version_ 1784597601362903040
author Molina-Vega, María
Gutiérrez-Repiso, Carolina
Lima-Rubio, Fuensanta
Suárez-Arana, María
Linares-Pineda, Teresa María
Cobos Díaz, Andrés
Tinahones, Francisco J.
Morcillo, Sonsoles
Picón-César, María J.
author_facet Molina-Vega, María
Gutiérrez-Repiso, Carolina
Lima-Rubio, Fuensanta
Suárez-Arana, María
Linares-Pineda, Teresa María
Cobos Díaz, Andrés
Tinahones, Francisco J.
Morcillo, Sonsoles
Picón-César, María J.
author_sort Molina-Vega, María
collection PubMed
description Objective: To analyze the effect of applying alternative diagnostic criteria for gestational diabetes mellitus (GDM) during the COVID-19 pandemic on GDM prevalence and obstetrical and perinatal outcomes, in comparison to usual diagnostic approaches. Methods: Data from women referred to GDM diagnosis from 1 September to 30 November 2019 were retrospectively collected (2019-group). The same data from the same period in 2020 were prospectively collected (2020-group). In both cases, a two-step diagnostic approach was used, the first step being a screening test (1 h 50 goral glucose tolerance test, OGTT). In 2019 it was followed by a 100 gr OGTT for diagnosis. In 2020, this was replaced by a blood test for the measurement of plasma glucose and HbA1c, according to alternative GDM diagnostic criteria during the COVID-19 pandemic. Results: From 237 women in the 2019 group, 40 (16.9%) were diagnosed with GDM, while from 255 women in the 2020 group, 37 (14.5%) had GDM (p = 0.470). More women in the 2020 group, in comparison to the 2019 group, were nulligravid (41.9% vs. 47.2%, p = 0.013), had a personal history of GDM (11.4% vs. 4.6%, p = 0.013) and had macrosomia in previous pregnancies (10.2% vs. 2.1%, p = 0.001). Obstetrical and perinatal outcomes were similar when comparing women with GDM to non-GDM women in the 2019 and 2020 groups and between GDM women and non-GDM women. Conclusion: In a Spanish population, GDM prevalence during the COVID-19 pandemic using the alternative diagnostic criteria was similar to that found in 2019 using the usual diagnostic criteria. Despite women referred for GDM diagnosis during the pandemic having more GDM risk factors, obstetrical and perinatal outcomes were comparable to those observed before the pandemic.
format Online
Article
Text
id pubmed-8585066
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-85850662021-11-12 Impact of the Gestational Diabetes Diagnostic Criteria during the Pandemic: An Observational Study Molina-Vega, María Gutiérrez-Repiso, Carolina Lima-Rubio, Fuensanta Suárez-Arana, María Linares-Pineda, Teresa María Cobos Díaz, Andrés Tinahones, Francisco J. Morcillo, Sonsoles Picón-César, María J. J Clin Med Article Objective: To analyze the effect of applying alternative diagnostic criteria for gestational diabetes mellitus (GDM) during the COVID-19 pandemic on GDM prevalence and obstetrical and perinatal outcomes, in comparison to usual diagnostic approaches. Methods: Data from women referred to GDM diagnosis from 1 September to 30 November 2019 were retrospectively collected (2019-group). The same data from the same period in 2020 were prospectively collected (2020-group). In both cases, a two-step diagnostic approach was used, the first step being a screening test (1 h 50 goral glucose tolerance test, OGTT). In 2019 it was followed by a 100 gr OGTT for diagnosis. In 2020, this was replaced by a blood test for the measurement of plasma glucose and HbA1c, according to alternative GDM diagnostic criteria during the COVID-19 pandemic. Results: From 237 women in the 2019 group, 40 (16.9%) were diagnosed with GDM, while from 255 women in the 2020 group, 37 (14.5%) had GDM (p = 0.470). More women in the 2020 group, in comparison to the 2019 group, were nulligravid (41.9% vs. 47.2%, p = 0.013), had a personal history of GDM (11.4% vs. 4.6%, p = 0.013) and had macrosomia in previous pregnancies (10.2% vs. 2.1%, p = 0.001). Obstetrical and perinatal outcomes were similar when comparing women with GDM to non-GDM women in the 2019 and 2020 groups and between GDM women and non-GDM women. Conclusion: In a Spanish population, GDM prevalence during the COVID-19 pandemic using the alternative diagnostic criteria was similar to that found in 2019 using the usual diagnostic criteria. Despite women referred for GDM diagnosis during the pandemic having more GDM risk factors, obstetrical and perinatal outcomes were comparable to those observed before the pandemic. MDPI 2021-10-24 /pmc/articles/PMC8585066/ /pubmed/34768425 http://dx.doi.org/10.3390/jcm10214904 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Molina-Vega, María
Gutiérrez-Repiso, Carolina
Lima-Rubio, Fuensanta
Suárez-Arana, María
Linares-Pineda, Teresa María
Cobos Díaz, Andrés
Tinahones, Francisco J.
Morcillo, Sonsoles
Picón-César, María J.
Impact of the Gestational Diabetes Diagnostic Criteria during the Pandemic: An Observational Study
title Impact of the Gestational Diabetes Diagnostic Criteria during the Pandemic: An Observational Study
title_full Impact of the Gestational Diabetes Diagnostic Criteria during the Pandemic: An Observational Study
title_fullStr Impact of the Gestational Diabetes Diagnostic Criteria during the Pandemic: An Observational Study
title_full_unstemmed Impact of the Gestational Diabetes Diagnostic Criteria during the Pandemic: An Observational Study
title_short Impact of the Gestational Diabetes Diagnostic Criteria during the Pandemic: An Observational Study
title_sort impact of the gestational diabetes diagnostic criteria during the pandemic: an observational study
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8585066/
https://www.ncbi.nlm.nih.gov/pubmed/34768425
http://dx.doi.org/10.3390/jcm10214904
work_keys_str_mv AT molinavegamaria impactofthegestationaldiabetesdiagnosticcriteriaduringthepandemicanobservationalstudy
AT gutierrezrepisocarolina impactofthegestationaldiabetesdiagnosticcriteriaduringthepandemicanobservationalstudy
AT limarubiofuensanta impactofthegestationaldiabetesdiagnosticcriteriaduringthepandemicanobservationalstudy
AT suarezaranamaria impactofthegestationaldiabetesdiagnosticcriteriaduringthepandemicanobservationalstudy
AT linarespinedateresamaria impactofthegestationaldiabetesdiagnosticcriteriaduringthepandemicanobservationalstudy
AT cobosdiazandres impactofthegestationaldiabetesdiagnosticcriteriaduringthepandemicanobservationalstudy
AT tinahonesfranciscoj impactofthegestationaldiabetesdiagnosticcriteriaduringthepandemicanobservationalstudy
AT morcillosonsoles impactofthegestationaldiabetesdiagnosticcriteriaduringthepandemicanobservationalstudy
AT piconcesarmariaj impactofthegestationaldiabetesdiagnosticcriteriaduringthepandemicanobservationalstudy